CLINICAL_TRIALS
trial_result
· 2021-01-20
Clinical Trial Update: VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs [Phase 4]
Summary
Phase 4 trial update on Bactiguard ETT Evac device for preventing ventilator-associated pneumonia in Belgian ICUs.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bactiguard AB | Conditions: Ventilator-associated Pneumonia | Phase 4 | Status: COMPLETED